Rupinta, Edelyn Faye T.

HRN: 17-33-85  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2023
CEFUROXIME 1.5GM (VIAL)
11/18/2023
11/19/2023
IV
1.5 Gm
Q 8h
S/P Repeat LTCS W/ BTL
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: